Keio University

News

281-290 items (total 704)
Published on June 27, 2023

Development of a Targeted Therapy for Gut Bacteria Causing Primary Sclerosing Cholangitis, a Disease with Few Effective Treatments Other Than Liver Transplantation

Office of Communications and Public Relations

Published on June 22, 2023

Increase in Suicides among 10- to 24-Year-Olds during the COVID-19 Pandemic Confirmed to Be Significant Only among Girls and Women—Analysis of 10 Years of Suicide Data

Office of Communications and Public Relations

Published on June 20, 2023

Discovery of a Genetic Causal Relationship in the Onset of Adolescent Idiopathic Scoliosis—Genetically Lean Individuals Have a Higher Risk of Developing the Condition—

Office of Communications and Public Relations

Published on June 20, 2023

Human Engineered Heart Tissue Created In Vitro Using Collagen Extracted from the Heart—Making Mature Engineered Heart Tissue Available for Drug Discovery and Disease Modeling

Office of Communications and Public Relations

Published on June 19, 2023

Lower Stress Among Family Caregivers Receiving Continuous, Attentive Care from Their Family Doctor

Office of Communications and Public Relations

Published on June 19, 2023

Discovery of a Method to Enhance the Effectiveness of Gene Therapy for Vision Restoration: Toward Overcoming Blindness and Practical Application

Office of Communications and Public Relations

Published on June 15, 2023

Investigator-Initiated Clinical Trial Demonstrates Efficacy of Anti-PD-1 Antibody Therapy for Unresectable Advanced or Recurrent Cutaneous Epithelial Malignancies - Leading to a Supplemental Application for Partial Change in Approved Items of the Domestic Manufacturing and Marketing Approval for Opdivo® Intravenous Infusion -

Office of Communications and Public Relations

Published on June 13, 2023

The 92nd Kitasato Memorial Ceremony Held

School of Medicine/Graduate School of Medicine

Published on June 09, 2023

Keio University Ranked 32nd in the World for SDG 16: THE Impact Rankings 2023

Office of Communications and Public Relations

Published on June 09, 2023

Elucidating the Mechanism by Which B Cells Exacerbate Autoimmune Hepatitis: Toward the Development of Treatments for Refractory Patients

Office of Communications and Public Relations